Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development

Fig. 1

SETD1A is highly expressed in human OV specimens and indicated a poor prognosis. A Protein levels of SETD1A in OV tumor and paired adjacent non-tumor tissues analyzed by western blotting assays. N non-tumor tissues, T tumor tissue, n = 21. B The quantitated results of the western blot gels in A. **p < 0.01. Unpaired two-tailed t-test. C The expression of SETD1A in human OV specimens in the GSE cohort (GSE26712). *p < 0.05. Unpaired two-tailed t-test. Data are expressed as mean ± SD. D,E The overall survival (OS) between different SETD1A levels of OV patients from TCGA D and the GSE cohort (GSE63885) E. F,G The progression-free survival (PFS) between different SETD1A levels of OV patients from the GSE cohort (GSE63885, GSE26712).

Back to article page